Cochrane Systematic Review: Glucocorticoids for viral bronchiolitis in infants and young children
Fernandes RM, Bialy LM, Vandermeer B, Tjosvold L, Plint AC, Patel H, Johnson DW, Klassen TP, Hartling L.
Fernandes RM, Bialy LM, Vandermeer B, Tjosvold L, Plint AC, Patel H, Johnson ...
Objectives: To review the efficacy and safety of systemic and inhaled glucocorticoids in children with viral bronchiolitis.
Objectives: To review the efficacy and safety of systemic and inhaled glucocorticoids in children with viral bronchiolitis.
Cochrane Systematic Review: Heliox inhalation therapy for bronchiolitis in infants
Liet JM, Ducruet T, Gupta V, Cambonie G.
Liet JM, Ducruet T, Gupta V, Cambonie G.
Objectives: To assess heliox in addition to standard medical care for acute bronchiolitis in infants.
Objectives: To assess heliox in addition to standard medical care for acute bronchiolitis in infants.
Cochrane Systematic Review: Nebulised deoxyribonuclease for viral bronchiolitis in children younger than 24 months
Enriquez A, Chu IW, Mellis C, Lin WY.
Enriquez A, Chu IW, Mellis C, Lin WY.
Objectives: To determine the effect of nebulised rhDNase on the severity and duration of viral bronchiolitis in children younger than 24 months of age in the hospital setting.
Objectives: To determine the effect of nebulised rhDNase on the severity and duration of viral bronchiolitis in children younger than 24 months of age in the hospital setting.
Cochrane Systematic Review: Nebulised hypertonic saline solution for acute bronchiolitis in infants
Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP.
Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP.
Objectives: To assess the effects of nebulised hypertonic ( 3%) saline solution in infants with viral bronchiolitis.
Objectives: To assess the effects of nebulised hypertonic ( 3%) saline solution in infants with viral bronchiolitis.
Cochrane Systematic Review: Glucocorticoids for viral bronchiolitis in infants and young children
Fernandes RM, Bialy LM, Vandermeer B, Tjosvold L, Plint AC, Patel H, Johnson DW, Klassen TP, Hartling L.
Fernandes RM, Bialy LM, Vandermeer B, Tjosvold L, Plint AC, Patel H, Johnson ...
Objectives: To review the efficacy and safety of systemic and inhaled glucocorticoids in children with viral bronchiolitis.
Objectives: To review the efficacy and safety of systemic and inhaled glucocorticoids in children with viral bronchiolitis.
Cochrane Systematic Review: Heliox inhalation therapy for bronchiolitis in infants
Liet JM, Ducruet T, Gupta V, Cambonie G.
Liet JM, Ducruet T, Gupta V, Cambonie G.
Objectives: To assess heliox in addition to standard medical care for acute bronchiolitis in infants.
Objectives: To assess heliox in addition to standard medical care for acute bronchiolitis in infants.
Cochrane Systematic Review: Nebulised deoxyribonuclease for viral bronchiolitis in children younger than 24 months
Enriquez A, Chu IW, Mellis C, Lin WY.
Enriquez A, Chu IW, Mellis C, Lin WY.
Objectives: To determine the effect of nebulised rhDNase on the severity and duration of viral bronchiolitis in children younger than 24 months of age in the hospital setting.
Objectives: To determine the effect of nebulised rhDNase on the severity and duration of viral bronchiolitis in children younger than 24 months of age in the hospital setting.
Cochrane Systematic Review: Nebulised hypertonic saline solution for acute bronchiolitis in infants
Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP.
Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP.
Objectives: To assess the effects of nebulised hypertonic ( 3%) saline solution in infants with viral bronchiolitis.
Objectives: To assess the effects of nebulised hypertonic ( 3%) saline solution in infants with viral bronchiolitis.